Weave Bio’s CEO and Co-founder, Brandon Rice, was recently featured on ISPE’s Future of Pharma podcast to discuss how The Weave Platform is transforming the way regulatory submissions are prepared.

In the episode, Brandon explains how our AI-native platform reduces the time it takes to generate submission-ready documents—from months of manual effort down to hours—while keeping human oversight at the center of the process. He shares insights on:

• The bottlenecks in traditional regulatory submissions and how automation helps overcome them
• The importance of accuracy, transparency, and human judgment in AI-assisted workflows
• How adoption of AI in pharma varies across company size and culture
• Global regulatory perspectives, including FDA’s growing interest in AI and EMA’s clearer guidance

Brandon emphasizes that AI is not replacing regulatory experts—it’s a powerful tool to help them work faster, with more focus on science and patients.

‍